These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 417345)

  • 21. High-pressure liquid chromatography analysis of benzo(a)pyrene metabolism by microsomal enzymes from rhesus liver and lung.
    Hundley SG; Freudenthal RI
    Cancer Res; 1977 Jan; 37(1):244-9. PubMed ID: 401471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between plasma antipyrine half-lives and hepatic microsomal drug metabolism in dogs.
    Vesell ES; Lee CJ; Passananti GT; Shively CA
    Pharmacology; 1973; 10(6):317-28. PubMed ID: 4150321
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
    Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of phenobarbital steady state levels on antipyrine clearance and distribution in the rat.
    Pei YY; Bialer M; Levy RH
    Biopharm Drug Dispos; 1986; 7(1):11-9. PubMed ID: 3955196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of halofenate on binding of various drugs to human plasma proteins and on the plasma half-life of antipyrine in monkeys.
    Hucker HB; Stauffer SC; White SE
    J Pharm Sci; 1972 Sep; 61(9):1490-2. PubMed ID: 4115915
    [No Abstract]   [Full Text] [Related]  

  • 26. Oxidative drug metabolism and inducibility by phenobarbital in sickle cell anemia.
    Anderson KE; Peterson CM; Alvares AP; Kappas A
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):580-7. PubMed ID: 913026
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
    McManus ME; Ilett KF
    Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
    Reimann G; Barthel B; Rockstroh JK; Spatz D; Brockmeyer NH
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):562-6. PubMed ID: 10584978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in drug metabolism in children with thyroid disorders.
    Saenger P; Rifkind AB; New MI
    J Clin Endocrinol Metab; 1976 Jan; 42(1):155-9. PubMed ID: 1249184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
    Grossman SJ; Herold EG; Drey JM; Alberts DW; Umbenhauer DR; Patrick DH; Nicoll-Griffith D; Chauret N; Yergey JA
    Drug Metab Dispos; 1993; 21(6):1029-36. PubMed ID: 7905381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
    Tse FL; Chang T; Jaffe JM
    Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
    De Mey C; Meineke I; Steinijans VW; Huber R; Hartmann M; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):98-106. PubMed ID: 8004366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-protein binding: a method for studying the interactions of drugs with bishydroxycoumarin (dicoumarol) in dogs.
    Welch RM
    Ann N Y Acad Sci; 1973 Nov; 226():259-66. PubMed ID: 4129139
    [No Abstract]   [Full Text] [Related]  

  • 34. Elimination of antipyrine and benzo[a]pyrene metabolism in cultured human lymphocytes.
    Kellermann G; Luyten-Kellermann M; Horning MG; Stafford M
    Clin Pharmacol Ther; 1976 Jul; 20(1):72-80. PubMed ID: 1277727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man.
    Davies DS; Thorgeirsson SS
    Ann N Y Acad Sci; 1971 Jul; 179():411-20. PubMed ID: 5285386
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of drug pretreatment on antipyrine levels in blood and tissues: an example of multiple drug interactions.
    Sotaniemi EA
    Pharmacology; 1973; 10(5):306-16. PubMed ID: 4764537
    [No Abstract]   [Full Text] [Related]  

  • 37. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
    van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
    Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-pressure liquid chromatographic analysis of benzo(a)pyrene metabolism by human lymphocytes from donors of different aryl hydrocarbon hydroxylase inducibility and antipyrine half-lives.
    Gurtoo HL; Vaught JB; Marinello AJ; Paigen B; Gessner T; Bolanowska W
    Cancer Res; 1980 Apr; 40(4):1305-10. PubMed ID: 7357559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver microsomal oxidations in baboon (Papio papio).
    Gee SJ; Krieger RI
    Xenobiotica; 1979 Aug; 9(8):467-73. PubMed ID: 117644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.